Clin2
NCT06355414Possibly a fitRecruiting

Psilocybin for chronic back pain and depression

Chronic Low-back PainDepression

Treatments studied

Part of Mental health, Pain clinical trials.

This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
21 years to 80 years
Study type
Interventional

Who can take part

  • You are between 21 and 80 years old.
  • You have had low back pain for at least 3 months, and it has bothered you on most days for the past 6 months.
  • You have at least moderate depression symptoms (score of 17 or more on a depression rating scale).
  • You can speak and read English fluently and have a high school diploma or equivalent.
  • You are willing to avoid certain medications, supplements, and recreational drugs around the study sessions.
  • You have not used psychedelic drugs more than 10 times in your life and none in the past 5 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04123314Recruiting· Early Phase 1
Psilocybin study for depression in mild memory or early Alzheimer’s

This early-phase study tests whether psilocybin (a psychedelic substance) can help with depression in people who have mild memory problems or early Alzheimer’s. The trial also closely monitors safety, thinking changes, mood, and blood pressure before and after dosing.

Baltimore, Maryland
NCT06512194Recruiting· Phase 2
Psilocybin for depression study

This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.

Edwards, Colorado
NCT07582120Not yet recruiting· Phase 2
Psilocybin-Assisted Therapy for Depression

This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.

St Louis, Missouri
NCT06518720Recruiting· Phase 2
Psilocybin for Chronic Nerve Pain and Depression

This trial tests whether psilocybin (a psychedelic medication) can help people who have both chronic nerve pain and depression that hasn't responded to standard treatments. The goal is to see if it can reduce pain and improve mood.

Toronto, Ontario
NCT07306364Not yet recruiting· Phase 2
Psilocybin plus physical therapy for chronic low back pain

This study tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with physical therapy can help relieve chronic low back pain. It aims to see if this approach can reduce pain and improve your ability to do daily activities.

New Haven, Connecticut
NCT06731335Recruiting· Phase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments

This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.

Toronto, Ontario

Hear when a new Chronic Low Back Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.